Marie labus (@marie_labus) profile picture

Experienced Chief Executive, board member, and fundraiser, with particular expertise in the commercialisation of university technologies.

Newcastle Upon Tyne, England
Joined April 2019
The future is bright for @AMLoBiosciences
This Post is from an account that no longer exists. Learn more
1
76
At the start of our session yesterday, the CEO of @AMLoBiosciences told us about some of the limiting factors for innovators in the UK 👇
3
5
1
5
2,796
The UK has fantastic researchers and innovators up and down our country who make life better for all of us. But too often we don't hear enough about them. As the first of our new @CommonsSITC showcases, I invited Newcastle's @AMLoBiosciences to @UKParliament to share their story
5
3
1
14
2,856
Another example of how #AMBLor is being used in the US to help Medical Professionals reassurance melanoma patients following their diagnosis. @AMLoBiosciences @Northern_Acc @NorthstarVent @newcastlehelix
This Post is from an account that no longer exists. Learn more
1
2
61
AMBLor – a groundbreaking histopathological biomarker test from @AMLoBiosciences has been awarded the UKCA mark. medtechtomarket.com/latest-n… #diagnostics #IVD #mediacaldevice
1
1
3
71
The culmination of years of hard work but #AMBLor is now available for healthcare professionals in GB. @Northern_Acc @NewcastleHosps @Bionow @MedilinkNOE @NorthstarVent
This Post is from an account that no longer exists. Learn more
4
88
Great to see our own Professor Phil Sloan will be at #SMR2024 presenting the latest results for this important research project #melanoma @Northern_Acc @MedilinkNOE @newcastlehelix
This Post is from an account that no longer exists. Learn more
1
67
Alcohol on trains- I’d be for a complete ban. Currently on a 9.30am @LNER train from Kings Cross, surrounded by a group of rowdy lads drinking consistently throughout. Had to ask one loitering in the aisle with his ass leaning on my shoulder to move. Not acceptable!
87
Still reeling from winning Best Partnership with Academia at the @MedilinkNOE Healthcare Awards. Our collaboration with @UniofNewcastle was selected for its significant impact for melanoma patients. Big thanks to all the @AMLoBiosciences staff, our collaborators, and investors.
1
1
5
1,336
The programme features a visit to @UniofNewcastle that, with funding from us, has developed a pioneering test which reliably predicts which people's early-stage melanomas are at low risk of recurring.  business.itn.co.uk/programme… @AMLoBiosciences @penny_lovat
2
1
174
As a company @AMLoBiosciences are working hard to bring innovate products to market to facilitate personalised care for people with melanoma. An important consequence of this is the more effective use of healthcare resources and the reduction of waste. #RealisticMed #AMBLor
This Post is from an account that no longer exists. Learn more
1
60
No one likes late surprises in early stage melanoma: “Surprisingly 25% of distant metastases occurred 5 years or later” -stage I/II data from Yevgeniy Semenov @MGHMedicine #SMR23 @SocietyMelanoma More to come soon from @DocDavidSavage @BenSwitzerDO @RujulParikh #spoilers
1
4
9
908
Are current follow-up recommendations for melanoma patients adequate? Unfortunately this study found that evidence supporting current guidance is sparse. The use of a biomarker test #AMBLor could help direct appropriate follow up for melanoma patients. @AMLoBiosciences
Are current follow-up recommendations for melanoma patients adequate? Our new study in @BMJ_Open led by @KunongaPatience finds sparse evidence supporting existing models. Link: shorturl.at/ruEIN @dawn_craig #melanoma #followupcare #evidencesynthesis #systematicreview RT
1
2
2
271
Fabulous to see @AMLoBiosciences own @VJMeaney talking to @ChiOnwurah about our prognostic test for early-stage melanoma.
Brilliant to attend @BIVDA’s parliamentary reception to hear about improvements in medical diagnostics. It was great to speak to Jane Meaney again about how fantastic Newcastle based @AMLoBiosciences could transform cancer treatment.
2
108
Was great to attend this event at @NHSEngland and talk to @RhonddaBryant about our innovate prognostic test for early stage melanoma. AMBLor was discovered using funding from @focusonmelanoma and we are striving to make AMBLor available for NHS patients. . #melanoma
This Post is from an account that no longer exists. Learn more
5
197
Interesting article from @CR_UK. Melanoma continues to increase. In older people exposure to UV in their youth is leading the skin cancers in later life. @AMLoBiosciences is developing tests to help the NHS manage this time bomb by improving patient management and anxiety.
Melanoma skin cancer cases in the UK have reached an all-time high. With 17,500 cases being diagnosed per year, our projections revealed these numbers could continue to increase by around 50% over the next 20 years. Find out what’s causing this 👇 1/2 bit.ly/3O2o4Bu
77
Disappointed that @thesightseepass is advertising a NY city pass for attractions with unlimited hop on hop off bus for the duration of the pass, only to find that the bus pass is for one day only! FAQs clearly stated it’s valid for whole trip. Company dismissive- best avoided!
80
Fabulous to see recognition for @AMLoBiosciences CSO @penny_lovat at #BAD2023. She presented the latest validation data for #AMBLor showing it’s utility in identifying genuinely low-risk, early- stage melanomas.
Fascinitating talk from @penny_lovat presenting the AMBLor technology @AMLoBiosciences to identify low-risk, non-ulcerated cutaneous melanomas. An inspiring journey of translation from the bench to the bedside.
1
189
It was great to host @ChiOnwurah at @AMLoBiosciences in our offices and lab @BiosphereNCL and show her the work we are doing with our AMBLor test. Using AMBLor can help alleviate patient anxiety by identifying those melanomas at low risk of spread. @Northern_Acc @newcastlehelix
This Post is from an account that no longer exists. Learn more
1
3
236